NO20010953L - En fremgangsmåte for behandling av stafylokokkal sykdom - Google Patents

En fremgangsmåte for behandling av stafylokokkal sykdom

Info

Publication number
NO20010953L
NO20010953L NO20010953A NO20010953A NO20010953L NO 20010953 L NO20010953 L NO 20010953L NO 20010953 A NO20010953 A NO 20010953A NO 20010953 A NO20010953 A NO 20010953A NO 20010953 L NO20010953 L NO 20010953L
Authority
NO
Norway
Prior art keywords
treatment
staphylococcal disease
staphylococcal
disease
Prior art date
Application number
NO20010953A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010953D0 (no
Inventor
Michael M Climo
Gordon L Archer
Beth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of NO20010953D0 publication Critical patent/NO20010953D0/no
Publication of NO20010953L publication Critical patent/NO20010953L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24075—Lysostaphin (3.4.24.75)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20010953A 1998-08-27 2001-02-26 En fremgangsmåte for behandling av stafylokokkal sykdom NO20010953L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/140,732 US6028051A (en) 1997-07-23 1998-08-27 Method for the treatment of staphylococcal disease
PCT/US1999/020396 WO2000012049A2 (en) 1998-08-27 1999-08-27 A method for the treatment of staphylococcal disease

Publications (2)

Publication Number Publication Date
NO20010953D0 NO20010953D0 (no) 2001-02-26
NO20010953L true NO20010953L (no) 2001-03-21

Family

ID=22492556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010953A NO20010953L (no) 1998-08-27 2001-02-26 En fremgangsmåte for behandling av stafylokokkal sykdom

Country Status (12)

Country Link
US (1) US6028051A (https=)
EP (1) EP1107722B1 (https=)
JP (1) JP2002523437A (https=)
AR (1) AR023645A1 (https=)
AT (1) ATE493145T1 (https=)
AU (1) AU5811199A (https=)
CA (1) CA2341699A1 (https=)
DE (1) DE69943089D1 (https=)
IL (1) IL141648A0 (https=)
NO (1) NO20010953L (https=)
WO (1) WO2000012049A2 (https=)
ZA (1) ZA995444B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091332B1 (en) 1998-06-22 2006-08-15 University Of Vermont Treatment of staphylococcus infections
US6875903B2 (en) * 1998-06-22 2005-04-05 University Of Vermont Treatment of Staphylococcus infections
US6569830B1 (en) 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
EP1465990B1 (en) * 2001-12-21 2011-07-13 Biosynexus Incorporated Truncated lysostaphin molecule with enhanced staphylolytic activity
US20030211995A1 (en) * 2001-12-21 2003-11-13 Kokai-Kun John Fitzgerald Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
US6759881B2 (en) * 2002-03-22 2004-07-06 Rambus Inc. System with phase jumping locked loop circuit
US7572439B2 (en) * 2002-03-26 2009-08-11 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
WO2003082926A2 (en) * 2002-03-26 2003-10-09 Biosynexus Incorporated Antimicrobial polymer conjugates
AU2003296937A1 (en) * 2002-12-10 2004-06-30 Biosynexus Incorporated Topical anti-infective formulations
US20100221237A1 (en) * 2003-03-26 2010-09-02 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
US20070190542A1 (en) * 2005-10-03 2007-08-16 Ling Xinsheng S Hybridization assisted nanopore sequencing
US20080095756A1 (en) * 2006-09-05 2008-04-24 Biosynexus Incorporated Compositions Comprising Lysostaphin Variants And Methods Of Using The Same
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
US20090304673A1 (en) * 2008-06-10 2009-12-10 Bernd Buchberger Method of Treatment of Inflammatory Diseases
WO2015175774A1 (en) 2014-05-14 2015-11-19 Trustees Of Dartmouth College Deimmunized lysostaphin and methods of use
RU2718554C1 (ru) 2017-09-25 2020-04-08 Георгий Георгиевич Чумбуридзе Термостабильная композиция, обладающая антивирусной и антибактериальной активностью и ее использование
CA3120255A1 (en) * 2018-11-19 2020-05-28 Nordmark Ip Gmbh Ancrod for the treatment or prophylaxis of endocarditis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
US5858962A (en) * 1987-05-11 1999-01-12 Ambi Inc. Composition for treating mastitis and other staphylococcal infections
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases

Also Published As

Publication number Publication date
EP1107722B1 (en) 2010-12-29
NO20010953D0 (no) 2001-02-26
IL141648A0 (en) 2002-03-10
ATE493145T1 (de) 2011-01-15
WO2000012049A2 (en) 2000-03-09
JP2002523437A (ja) 2002-07-30
AU5811199A (en) 2000-03-21
ZA995444B (en) 2000-07-10
DE69943089D1 (de) 2011-02-10
CA2341699A1 (en) 2000-03-09
EP1107722A4 (en) 2006-05-17
WO2000012049A3 (en) 2000-05-25
US6028051A (en) 2000-02-22
AR023645A1 (es) 2002-09-04
EP1107722A2 (en) 2001-06-20

Similar Documents

Publication Publication Date Title
DE69626151D1 (de) Endoskop
DE19681437T1 (de) Endoskop
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
DE69814070D1 (de) Sterilisationsverfahren
FI20000863L (fi) Uusi hoitomenetelmä
ID16345A (id) Senyawa-senyawa heterosiklik
BR9607097A (pt) Novos compostos
NO975690L (no) Fremgangsmåte for forbedring av dyrehelse
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
FI20030162L (fi) Uusia yhdisteitä
NO20010953L (no) En fremgangsmåte for behandling av stafylokokkal sykdom
ID30339A (id) Metode pengobatan baru
NO20005179D0 (no) Medikament behandling
ID17723A (id) Senyawa untuk pengobatan
BR9610214A (pt) Compostos farmacéuticos
NO982566D0 (no) Forbindelser
IS4789A (is) Meðferðarefnasambönd
NO961498D0 (no) Fremgangsmåte for oppfanging av svovelforbindelser
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20003214D0 (no) FremgangsmÕte for fremstilling av elastomerer
ID16924A (id) Metode perlakuan poliolefin
NO965448D0 (no) Farmasöytiske forbindelser
NO20006383L (no) Fremgangsmåte for behandling
NO996166D0 (no) Fremgangsmåte for behandling av avluter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application